Involvement of the dopaminergic system in the reward-related behavior of pregabalin
Abstract There has been an increase in cases of drug addiction and prescription drug abuse worldwide. Recently, pregabalin abuse has been a focus for many healthcare agencies, as highlighted by epidemiological studies. We previously evaluated the possibility of pregabalin abuse using the conditioned...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3398dfba11a247c8abe43f67d64910f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3398dfba11a247c8abe43f67d64910f4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3398dfba11a247c8abe43f67d64910f42021-12-02T14:58:45ZInvolvement of the dopaminergic system in the reward-related behavior of pregabalin10.1038/s41598-021-88429-82045-2322https://doaj.org/article/3398dfba11a247c8abe43f67d64910f42021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88429-8https://doaj.org/toc/2045-2322Abstract There has been an increase in cases of drug addiction and prescription drug abuse worldwide. Recently, pregabalin abuse has been a focus for many healthcare agencies, as highlighted by epidemiological studies. We previously evaluated the possibility of pregabalin abuse using the conditioned place preference (CPP) paradigm. We observed that a 60 mg/kg dose could induce CPP in mice and that pregabalin-rewarding properties were mediated through glutamate neurotransmission. Notably, the dopaminergic reward circuitry is also known to play a crucial role in medication-seeking behavior. Therefore, this study aimed to explore the possible involvement of dopaminergic receptor-1 in pregabalin-induced CPP. Mice were randomly allocated to receive saline or the dopamine-1 receptor antagonist SKF-83566 (0.03 mg/kg, intraperitoneal). After 30 min, the mice received either saline or pregabalin (60 mg/kg) during the conditioning phase. Among the control groups that received saline or SKF-83566, the time spent in the two conditioning chambers was not significantly altered. However, among the pregabalin-treated group, there was a marked increase in the time spent in the drug-paired chamber compared to the time spent in the vehicle-paired chamber. Notably, blocking dopamine-1 receptors with SKF-83566 completely prevented pregabalin-induced place preference, thus demonstrating the engagement of the dopaminergic system in pregabalin-induced reward-related behavior.Yusuf S. AlthobaitiFarooq M. AlmutairiFahad S. AlshehriEbtehal AltowairqiAliyah M. MarghalaniAmal A. AlghorabiWalaa F. AlsanieAhmed GaberHashem O. AlsaabAtiah H. AlmalkiAlqassem Y. HakamiTurki AlkhalifaAhmad D. AlmalkiAna M. G. HardyZahoor A. ShahNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Yusuf S. Althobaiti Farooq M. Almutairi Fahad S. Alshehri Ebtehal Altowairqi Aliyah M. Marghalani Amal A. Alghorabi Walaa F. Alsanie Ahmed Gaber Hashem O. Alsaab Atiah H. Almalki Alqassem Y. Hakami Turki Alkhalifa Ahmad D. Almalki Ana M. G. Hardy Zahoor A. Shah Involvement of the dopaminergic system in the reward-related behavior of pregabalin |
description |
Abstract There has been an increase in cases of drug addiction and prescription drug abuse worldwide. Recently, pregabalin abuse has been a focus for many healthcare agencies, as highlighted by epidemiological studies. We previously evaluated the possibility of pregabalin abuse using the conditioned place preference (CPP) paradigm. We observed that a 60 mg/kg dose could induce CPP in mice and that pregabalin-rewarding properties were mediated through glutamate neurotransmission. Notably, the dopaminergic reward circuitry is also known to play a crucial role in medication-seeking behavior. Therefore, this study aimed to explore the possible involvement of dopaminergic receptor-1 in pregabalin-induced CPP. Mice were randomly allocated to receive saline or the dopamine-1 receptor antagonist SKF-83566 (0.03 mg/kg, intraperitoneal). After 30 min, the mice received either saline or pregabalin (60 mg/kg) during the conditioning phase. Among the control groups that received saline or SKF-83566, the time spent in the two conditioning chambers was not significantly altered. However, among the pregabalin-treated group, there was a marked increase in the time spent in the drug-paired chamber compared to the time spent in the vehicle-paired chamber. Notably, blocking dopamine-1 receptors with SKF-83566 completely prevented pregabalin-induced place preference, thus demonstrating the engagement of the dopaminergic system in pregabalin-induced reward-related behavior. |
format |
article |
author |
Yusuf S. Althobaiti Farooq M. Almutairi Fahad S. Alshehri Ebtehal Altowairqi Aliyah M. Marghalani Amal A. Alghorabi Walaa F. Alsanie Ahmed Gaber Hashem O. Alsaab Atiah H. Almalki Alqassem Y. Hakami Turki Alkhalifa Ahmad D. Almalki Ana M. G. Hardy Zahoor A. Shah |
author_facet |
Yusuf S. Althobaiti Farooq M. Almutairi Fahad S. Alshehri Ebtehal Altowairqi Aliyah M. Marghalani Amal A. Alghorabi Walaa F. Alsanie Ahmed Gaber Hashem O. Alsaab Atiah H. Almalki Alqassem Y. Hakami Turki Alkhalifa Ahmad D. Almalki Ana M. G. Hardy Zahoor A. Shah |
author_sort |
Yusuf S. Althobaiti |
title |
Involvement of the dopaminergic system in the reward-related behavior of pregabalin |
title_short |
Involvement of the dopaminergic system in the reward-related behavior of pregabalin |
title_full |
Involvement of the dopaminergic system in the reward-related behavior of pregabalin |
title_fullStr |
Involvement of the dopaminergic system in the reward-related behavior of pregabalin |
title_full_unstemmed |
Involvement of the dopaminergic system in the reward-related behavior of pregabalin |
title_sort |
involvement of the dopaminergic system in the reward-related behavior of pregabalin |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/3398dfba11a247c8abe43f67d64910f4 |
work_keys_str_mv |
AT yusufsalthobaiti involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT farooqmalmutairi involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT fahadsalshehri involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT ebtehalaltowairqi involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT aliyahmmarghalani involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT amalaalghorabi involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT walaafalsanie involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT ahmedgaber involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT hashemoalsaab involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT atiahhalmalki involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT alqassemyhakami involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT turkialkhalifa involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT ahmaddalmalki involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT anamghardy involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin AT zahoorashah involvementofthedopaminergicsystemintherewardrelatedbehaviorofpregabalin |
_version_ |
1718389256946188288 |